申请人:GUANGDONG ZHONGSHENG PHARMACEUTICAL CO., LTD
公开号:EP3312179A1
公开(公告)日:2018-04-25
Disclosed is a fused-ring or tricyclic aryl pyrimidine compound used as a mutation selectivity EGFR inhibitor. Specifically, disclosed is a compound represented by formula (I) and used as an EGFR inhibitor or a pharmaceutically acceptable salt thereof.
公开了一种作为突变选择性
表皮生长因子受体
抑制剂的融合环或
三环芳基
嘧啶化合物。具体地说,公开了一种由式(I)代表并用作
表皮生长因子受体
抑制剂的化合物或其药学上可接受的盐。